Summit Financial’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$87.1K Buy
11,386
+345
+3% +$2.64K ﹤0.01% 1386
2025
Q4
$107K Buy
11,041
+941
+9% +$8K ﹤0.01% 1268
2025
Q3
$42.3K Buy
+10,100
New +$64.5K ﹤0.01% 1232

Other funds holding REPL

Summit Financial's REPL Position: Q1 2026 in Review

Summit Financial increased its Replimune Group (REPL) stake by 3.1% in Q1 2026, buying an estimated $2.64K and bringing the position to 11,386 shares worth $87.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1386.

Summit Financial first reported a position in REPL in Q3 2025 and has held it in 3 quarters since. The position peaked at $107K in Q4 2025. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • Summit Financial held 11,386 shares of Replimune Group worth $87.1K as of Q1 2026.
  • Summit Financial bought 345 Replimune Group shares in Q1 2026, an estimated $2.64K.
  • Replimune Group made up ﹤0.01% of Summit Financial's portfolio in Q1 2026, its #1386 holding.
  • Summit Financial first reported a position in Replimune Group in Q3 2025 and has held it in 3 quarters since.
  • Summit Financial's Replimune Group position peaked at $107K in Q4 2025.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on Summit Financial's 13F filing for Q1 2026, filed 15 May 2026.